Lobbying Activity Report

5851-44471

Organization: Emergent BioSolutions Canada Inc.
Associated registration: 10844-5851-1
Lobbying Activity date: 2025-07-23
Arranged a meeting: No
Posted date: 2025-08-05

In-house lobbyists who participated in the lobbying activity: Dvorah Richler
Shawn McLaren
Danielle Portnik
Senior Public Office Holders who were lobbied in this activity: Katherine Mackenzie, Director Substance Use Policy
Health
 
Subject Matter of the Lobbying Activity
Specific Topics of Lobbying Communications Intended Outcomes Associated Subject Matters
To increase public access and funding for NARCAN® (Naloxone HCI) Nasal Spray in BC.
  • Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity
  • Awarding, amendment or termination of any contract, grant or financial benefit by or on behalf of the government of British Columbia or a Provincial entity
 Colleges & Universities, Emergency Preparedness, Health, Mental Health and Addictions
 
Senior officer who filed this Lobbying Activity Report: Paul Williams
 
The above name is that of the most senior paid officer who is responsible for filing a Lobbying Activity Report for the organization (the Designated Filer), whether that person participated in this lobbying activity or not.
Date Modified: